Clinical trial
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution, 0.1% vs. Placebo for Treatment of Ocular Inflammation Following Cataract Surgery
NCT00198445 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Topical Bromfenac Ophthalmic Solution, 0.1% vs. Placebo for Treatment of Ocular Inflammation Following Cataract Surgery
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- January 31, 2004
- Enrollment
- 527 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.